Pathological aspects of lipid peroxidation

References

• Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991;91:31S–38S.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291-295.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Coatrieux, C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 2008;153:6–20.
   PubMed Web of Science ®Google Scholar
• Schaur RJ. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 2003;24:149–159.
   PubMedGoogle Scholar
• Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 2005;49:1044–1049.
   PubMed Web of Science ®Google Scholar
• Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298–300.
   PubMedGoogle Scholar
• Beckman KB, Ames BN. Mitochondrial aging: open questions. Ann NY Acad Sci 1998;854:118–127.
   PubMed Web of Science ®Google Scholar
• Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547–581.
   PubMed Web of Science ®Google Scholar
• Harman D. The aging process. Proc Natl Acad Sci USA 1981;78:7124–7128.
   PubMed Web of Science ®Google Scholar
• Harman D. Free radicals in aging. Mol Cell Biochem 1988;84:155–161.
   PubMed Web of Science ®Google Scholar
• Harman D. The aging process: major risk factor for disease and death. Proc Natl Acad Sci USA 1991;88:5360–5363.
   PubMed Web of Science ®Google Scholar
• Harman D. Free radical theory of aging. Mutat Res 1992;275:257–266.
   PubMed Web of Science ®Google Scholar
• Harman D. Free radical involvement in aging. Pathophysiology and therapeutic implications. Drugs Aging 1993;3:60–80.
   PubMed Web of Science ®Google Scholar
• Harman D, Eddy DE, Noffsinger J. Free radical theory of aging: inhibition of amyloidosis in mice by antioxidants; possible mechanism. J Am Geriatr Soc 1976;24:203–210.
   PubMed Web of Science ®Google Scholar
• Grune T, Jung T, Merker K, Davies KJ. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease. Int J Biochem Cell Biol 2004;36:2519–2530.
   PubMed Web of Science ®Google Scholar
• Sohal RS, Orr WC. Relationship between antioxidants, prooxidants, and the aging process. Ann NY Acad Sci 1992;663:74–84.
   PubMed Web of Science ®Google Scholar
• Fleming JE, Miquel J, Cottrell SF, Yengoyan LS, Economos AC. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology 1982;28:44–53.
   PubMed Web of Science ®Google Scholar
• Fleming JE, Reveillaud I, Niedzwiecki A. Role of oxidative stress in Drosophila aging. Mutat Res 1992;275:267–279.
   PubMed Web of Science ®Google Scholar
• Yan LJ, Sohal RS. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci USA 1998;95:12896–12901.
   PubMed Web of Science ®Google Scholar
• Hohn A, Jung T, Grimm S, Grune T. Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells. Free Radic Biol Med. 2010;48:1100–1108.
   PubMed Web of Science ®Google Scholar
• Kirkwood TB, Kowald A. Network theory of aging. Exp Gerontol 1997;32:395–399.
   PubMed Web of Science ®Google Scholar
• Jang YC, Remmen VH. The mitochondrial theory of aging: insight from transgenic and knockout mouse models. Exp Gerontol 2009;44:256–260.
   PubMed Web of Science ®Google Scholar
• McCann SM, Licinio J, Wong ML, Yu WH, Karanth S, Rettorri V. The nitric oxide hypothesis of aging. Exp Gerontol 1998;33:813–826.
   PubMed Web of Science ®Google Scholar
• Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010;12:503–535.
   PubMed Web of Science ®Google Scholar
• Hannover A. Mikroskopiske undersögelser af nervesytemet. Kgl Danske Videsk Kabernes Selsskobe Naturv Math Ah (Copenhagen) 1842;10:1–12.
   Google Scholar
• Konneff JH. Beiträge zur kenntnis der nervenzellen der peripheren ganglien. Mitt Naturforsch Gesellsch Bern 1886;44:13–14.
   Google Scholar
• Brizee KR, Ordy JM, Kaakck B. Early appearance and regional differences in interneuronal and extraneuronal lipofuscin accumulation with age in the brain of a nonhuman primate (Macaca mulatta). J Gerontol 1974;29:366–381.
   PubMedGoogle Scholar
• Hammer C, Braum E. Quantification of age pigments (lipofuscin). Comp Biochem Physiol B 1988;90:7–17.
   PubMed Web of Science ®Google Scholar
• Hartoft WS. Ceroid. Am J Med Sci 1965;250:324–345.
   PubMed Web of Science ®Google Scholar
• Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med 1996;21:871–888.
   PubMed Web of Science ®Google Scholar
• Reichel E, Holander J, Clark HJ, Strehler BL. Lipofuscin pigment accumulation as a function of age and distributionin rodent brain. J Gerontol 1968;23:71–78.
   PubMedGoogle Scholar
• Miquel J, Tappel AL, Dillard CJ, Herman MM, Bensch KG. Fluorescent products and lysosomal components in aging Drosophila melanogaster. J Gerontol 1974;29:622–637.
   PubMedGoogle Scholar
• Sheldal JA, Tappel AL. Fluorescent products from aging Drosophila melanogaster. An indicator of free radical lipid proxidation damages. Exp Gerontol 1974;9:33–41.
   PubMed Web of Science ®Google Scholar
• Sohal RS. Fine structural alterations with age in the fat body of the adult male housefly, Musca domestica. Z. Zellforsch Mikrosk. Anatomie 1973;1973:169–175.
   Google Scholar
• Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von Zglinicki T, Davies KJ. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 2000;14:1490–1498.
   PubMed Web of Science ®Google Scholar
• Krohne TU, Kaemmerer E, Holz FG, Kopitz J. Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action. Exp Eye Res 2010;90:261–266.
   PubMed Web of Science ®Google Scholar
• Catalgol B, Ziaja I, Breusing N, Jung T, Hohn A, Alpertunga B, Schroeder P, Chondrogianni N, Gonos ES, Petropoulos I, Friguet B, Klotz LO, Krutmann J, Grune T. The proteasome is an integral part of solar ultraviolet a radiation-induced gene expression. J Biol Chem 2009;284:30076–30086.
   PubMed Web of Science ®Google Scholar
• Ahmed EK, Rogowska-Wrzesinska A, Roepstorff P, Bulteau AL, Friguet B. Protein modification and replicative senescence of WI-38 human embryonic fibroblasts. Aging Cell 2010;9:252–272.
   PubMed Web of Science ®Google Scholar
• Grune T, Merker K, Sandig G, Davies KJ. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 2003;305:709–718.
   PubMed Web of Science ®Google Scholar
• Friguet B, Stadtman ER, Szweda LI. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 1994;269:21639–21643.
   PubMed Web of Science ®Google Scholar
• Lippman RD. Rapid in vivo quantification and comparison of hydroperoxides and oxidized collagen in aging mice, rabbits and man. Exp Gerontol 1985;20:1–5.
   PubMed Web of Science ®Google Scholar
• Sharma SP, Wadhwa R. Effect of butylated hydroxytoluene on the life span of Drosophila bipectinata. Mech Ageing Dev 1983;23:67–71.
   PubMed Web of Science ®Google Scholar
• Rikans LE, Hornbrook KR. Lipid peroxidation, antioxidant protection and aging. Biochim Biophys Acta 1997;1362:116–127.
   PubMed Web of Science ®Google Scholar
• Siems W, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003;24:167–175.
   PubMedGoogle Scholar
• Voss P, Siems W. Clinical oxidation parameters of aging. Free Radic Res 2006;40:1339–1349.
   PubMed Web of Science ®Google Scholar
• Chia LS, Thompson JE, Moscarello MA. Changes in lipid phase behaviour in human myelin during maturation and aging. Involvement of lipid peroxidation. FEBS Lett 1983;157:155–158.
   PubMed Web of Science ®Google Scholar
• Sawada M, Carlson JC. Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat. Mech Ageing Dev 1987;41:125–137.
   PubMed Web of Science ®Google Scholar
• Hayakawa N, Yokoyama H, Kato H, Araki T. Age-related alterations of oxidative stress markers in the mouse hippocampal CA1 sector. Exp Mol Pathol 2008;85:135–140.
   PubMed Web of Science ®Google Scholar
• Zhang JR, Andrus PK, Hall ED. Age-related phospholipid hydroperoxide levels in gerbil brain measured by HPLC-chemiluminescence and their relation to hydroxyl radical stress. Brain Res 1994;639:275–282.
   PubMed Web of Science ®Google Scholar
• Kristofikova Z, Klaschka J, Tejkalova H. Effect of aging on lipid peroxide levels induced by L-glutamic acid and estimated by means of a thiobarbituric acid test in rat brain tissue. Exp Gerontol 1995;30:645–657.
   PubMed Web of Science ®Google Scholar
• Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett 2010;469:6–10.
   PubMed Web of Science ®Google Scholar
• Reed TT, Pierce WM, Markesbery WR, Butterfield DA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Res 2009;1274:66–76.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol 2009;44:625–633.
   PubMed Web of Science ®Google Scholar
• Gil L, Siems W, Mazurek B, Gross J, Schroeder P, Voss P, Grune T. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res 2006;40:495–505.
   PubMed Web of Science ®Google Scholar
• Ward WF, Qi W, Van Remmen H, Zackert WE, Roberts LJ, 2nd, Richardson A. Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. J Gerontol A Biol Sci Med Sci 2005;60:847–851.
   PubMed Web of Science ®Google Scholar
• Mendoza-Nunez VM, Ruiz-Ramos M, Sanchez-Rodriguez MA, Retana-Ugalde R, Munoz-Sanchez JL. Aging-related oxidative stress in healthy humans. Tohoku J Exp Med 2007;213:261–268.
   PubMed Web of Science ®Google Scholar
• Asselin C, Bouchard B, Tardif JC, Des Rosiers C. Circulating 4-hydroxynonenal-protein thioether adducts assessed by gas chromatography-mass spectrometry are increased with disease progression and aging in spontaneously hypertensive rats. Free Radic Biol Med 2006;41:97–105.
   PubMed Web of Science ®Google Scholar
• Depboylu B, Dogru-Abbasoglu S, Aykac-Toker G, Uysal M. Increased susceptibility of serum and apo-B-containing lipoproteins to peroxidation in aged rats. Clin Exp Med 2007;7:158–163.
   PubMed Web of Science ®Google Scholar
• Andriollo-Sanchez M, Hininger-Favier I, Meunier N, Venneria E, O'Connor JM, Maiani G, Coudray C, Roussel AM. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur J Clin Nutr 2005;59(Suppl 2):58–62.
   Google Scholar
• Mehmetcik G, Ozdemirler G, Kanbagli O, Toker G, Uysal M. Age-related changes in plasma lipid peroxidation and antioxidant system in humans and rats. Arch Gerontol Geriatr 1997;25:305–310.
   PubMed Web of Science ®Google Scholar
• Zarkovic K, Zarkovic N, Schlag G, Redl H, Waeg G. Histological aspect of sepsis-induced brain changes in baboon model. Berlin: Springer; 1996.
   Google Scholar
• Zarkovic K. 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 2003;24:293–303.
   PubMedGoogle Scholar
• Urabe T, Hattori N, Yoshikawa M, Yoshino H, Uchida K, Mizuno Y. Colocalization of Bcl-2 and 4-hydroxynonenal modified proteins in microglial cells and neurons of rat brain following transient focal ischemia. Neurosci Lett 1998;247:159–162.
   PubMed Web of Science ®Google Scholar
• Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689–695.
   PubMed Web of Science ®Google Scholar
• Sayre LM, Smith MA, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 2001;8:721–738.
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 1986;58:61–97.
   PubMedGoogle Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Uchida K, Stadtman ER. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci USA 1992;89:4544–4548.
   PubMed Web of Science ®Google Scholar
• Wataya T, Nunomura A, Smith MA, Siedlak SL, Harris PL, Shimohama S, Szweda LI, Kaminski MA, Avila J, Price DL, Cleveland DW, Sayre LM, Perry G. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J Biol Chem 2002;277:4644–4648.
   PubMed Web of Science ®Google Scholar
• Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 2003;24:281–291.
   PubMedGoogle Scholar
• Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct 1993;11:279–286.
   PubMed Web of Science ®Google Scholar
• Price DL, Sisodia SS, Gandy SE. Amyloid beta amyloidosis in Alzheimer’s disease. Curr Opin Neurol 1995;8:268–274.
   PubMed Web of Science ®Google Scholar
• Borghi R, Patriarca S, Traverso N, Piccini A, Storace D, Garuti A, Gabriella C, Patrizio O, Massimo T. The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. Neurobiol Aging 2007;28:1009–1014.
   PubMed Web of Science ®Google Scholar
• Cooper PN, Jackson M, Lennox G, Lowe J, Mann DM. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 1995;52:1011–1015.
   PubMedGoogle Scholar
• Rauk A. Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic? Dalton Trans 2008;57:1273–1282.
   Google Scholar
• Shringarpure R, Grune T, Sitte N, Davies KJ. 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer’s disease. Cell Mol Life Sci 2000;57:1802–1809.
   PubMed Web of Science ®Google Scholar
• Pettegrew JW, Moossy J, Withers G, McKeag D, Panchalingam K. 31P nuclear magnetic resonance study of the brain in Alzheimer’s disease. J Neuropathol Exp Neurol 1988;47235–248.
   Web of Science ®Google Scholar
• Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997;36:1–21.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 1998;273:13605–13612.
   PubMed Web of Science ®Google Scholar
• Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 1997;69:273–284.
   PubMed Web of Science ®Google Scholar
• Bruce-Keller AJ, Li YJ, Lovell MA, Kraemer PJ, Gary DS, Brown RR, Markesbery WR, Mattson MP. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 1998;57:257–267.
   PubMed Web of Science ®Google Scholar
• Hwang JJ, Lee SJ, Kim TY, Cho JH, Koh JY. Zinc and 4-hydroxy-2-nonenal mediate lysosomal membrane permeabilization induced by H2O2 in cultured hippocampal neurons. J Neurosci 2008;28:3114–3122.
   PubMed Web of Science ®Google Scholar
• Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997;17:5089–5100.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer’s disease. Neurobiol Aging 1997;18:457–461.
   PubMed Web of Science ®Google Scholar
• Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol Aging 1998;19:33–36.
   PubMed Web of Science ®Google Scholar
• Volkel W, Sicilia T, Pahler A, Gsell W, Tatschner T, Jellinger K, Leblhuber F, Riederer P, Lutz WK, Gotz ME. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease. Neurochem Int 2006;48:679–686.
   Web of Science ®Google Scholar
• Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol 1996;148:89–93.
   PubMed Web of Science ®Google Scholar
• Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu Rev Med 1996;47:387–400.
   PubMed Web of Science ®Google Scholar
• Montine TJ, Huang DY, Valentine WM, Amarnath V, Saunders A, Weisgraber KH, Graham DG, Strittmatter WJ. Crosslinking of apolipoprotein E by products of lipid peroxidation. J Neuropathol Exp Neurol 1996;55:202–210.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Xie C, Markesbery WR. Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 2001;22:187–194.
   PubMed Web of Science ®Google Scholar
• Marnett LJ. DNA adducts of alpha,beta-unsaturated aldehydes and dicarbonyl compounds. IARC Sci Publ 1994;125:151–163.
   Google Scholar
• Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N, Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem 1998;273:16058–16066.
   PubMed Web of Science ®Google Scholar
• Calingasan NY, Uchida K, Gibson GE. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer’s disease. J Neurochem 1999;72:751–756.
   PubMed Web of Science ®Google Scholar
• Stadtman ER. Protein oxidation and aging. Science 1992;257:1220–1224.
   PubMed Web of Science ®Google Scholar
• LoPachin RM, Barber DS, Gavin T. Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol Sci 2008;104:235–249.
   PubMed Web of Science ®Google Scholar
• Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N. Oxidative damage in Alzheimer’s. Nature 1996;382:120–121.
   PubMed Web of Science ®Google Scholar
• Duvoisin RC. The genetics of Parkinson’s disease. A review. Adv Neurol 1993;60:306–315.
   PubMedGoogle Scholar
• Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000;290:985–989.
   PubMed Web of Science ®Google Scholar
• Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 1991;56:978–982.
   PubMed Web of Science ®Google Scholar
• Khan FH, Saha M, Chakrabarti S. Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain. Brain Res 2001;895:245–249.
   PubMed Web of Science ®Google Scholar
• Agil A, Duran R, Barrero F, Morales B, Arauzo M, Alba F, Miranda MT, Prieto I, Ramirez M, Vives F. Plasma lipid peroxidation in sporadic Parkinson’s disease. Role of the L-dopa. J Neurol Sci 2006;240:31–36.
   PubMed Web of Science ®Google Scholar
• Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD, Jenner P, Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 1997;69:1196–1203.
   PubMed Web of Science ®Google Scholar
• Jenner P. Oxidative stress in Parkinson’s disease. Ann Neurol 2003;53(Suppl 3):S26–36;discussion S36–28.
   Google Scholar
• Leiphon LJ, Picklo MJ, Sr. Inhibition of aldehyde detoxification in CNS mitochondria by fungicides. Neurotoxicology 2007;28:143–149.
   PubMed Web of Science ®Google Scholar
• Aoyama K, Matsubara K, Kobayashi S. Aging and oxidative stress in progressive supranuclear palsy. Eur J Neurol 2006;13:89–92.
   PubMed Web of Science ®Google Scholar
• Fray AE, Ince PG, Banner SJ, Milton ID, Usher PA, Cookson MR, Shaw PJ. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur J Neurosci 1998;10:2481–2489.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O’Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak–Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH, Price DL, Sisodia SS, Cleveland DW. Superoxide-dismutase-1 with mutations linked to familial amyotrophic-lateral-sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994;91:8292–8296.
   PubMed Web of Science ®Google Scholar
• WiedauPazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE. Altered reactivity of superoxide dismutase in farmilial amyotrophic lateral sclerosis. Science 1996;271:515–518.
   PubMed Web of Science ®Google Scholar
• Beckman JS, Carson M, Smith CD, Koppenol WH. Als, sod and peroxynitrite. Nature 1993;364:584–584.
   PubMed Web of Science ®Google Scholar
• Shibata N, Hirano A, Kobayashi M, Siddique T, Deng HX, Hung WY, Kato T, Asayama K. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropath Exp Neur 1996;55:481–490.
   PubMed Web of Science ®Google Scholar
• Pedersen WA, Fu WM, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 1998;44:819–824.
   PubMed Web of Science ®Google Scholar
• Shibata N, Nagai R, Miyata S, Jono T, Horiuchi S, Hirano A, Kato S, Sasaki S, Asayama K, Kobayashi M. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol 2000;100:275–284.
   PubMed Web of Science ®Google Scholar
• Shibata N, Yamada S, Uchida K, Hirano A, Sakoda S, Fujimura H, Sasaki S, Iwata M, Toi S, Kawaguchi M, Yamamoto T, Kobayashi M. Accumulation of protein-bound 4-hydroxy-2-hexenal in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Brain Research 2004;1019:170–177.
   PubMed Web of Science ®Google Scholar
• Stocker R, Keaney JF, Jr. New insights on oxidative stress in the artery wall. J Thromb Haemost 2005;3:1825–1834.
   PubMed Web of Science ®Google Scholar
• Scott J. Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev 2004;14:271–279.
   PubMed Web of Science ®Google Scholar
• Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 2002;4:899–914.
   PubMed Web of Science ®Google Scholar
• Irani, K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000;87:179–183.
   PubMed Web of Science ®Google Scholar
• Clempus RE, Griendling KK. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 2006;71:216–225.
   PubMed Web of Science ®Google Scholar
• Yung LM, Leung FP, Yao X, Chen ZY, Huang Y. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Tagets 2006;6:1–19.
   PubMedGoogle Scholar
• Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 2003;14:421–430.
   PubMed Web of Science ®Google Scholar
• McEwen JE, Zimniak P, Mehta JL, Shmookler Reis RJ. Molecular pathology of aging and its implications for senescent coronary atherosclerosis. Curr Opin Cardiol 2005;20:399–406.
   PubMed Web of Science ®Google Scholar
• Berliner JA, Gharavi NM. Endothelial cell regulation by phospholipid oxidation products. Free Radic Biol Med 2008;45:119–123.
   PubMed Web of Science ®Google Scholar
• Berliner JA, Leitinger N, Tsimikas S. The role of oxidized phospholipids in atherosclerosis. J Lipid Res 2009;50(Suppl): 207–212.
   Google Scholar
• Ashraf MZ, Kar NS, Podrez EA. Oxidized phospholipids: biomarker for cardiovascular diseases. Int J Biochem Cell Biol 2009;41:1241–1244.
   PubMed Web of Science ®Google Scholar
• Szapacs ME, Kim HY, Porter NA, Liebler DC. Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe. J Proteome Res 2008;7:4237–4246.
   PubMed Web of Science ®Google Scholar
• Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96:2882–2891.
   PubMed Web of Science ®Google Scholar
• Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem 1989;264:5331–5334.
   PubMed Web of Science ®Google Scholar
• Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Gugiu B, Fox PL, Hoff HF, Salomon RG, Hazen SL. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 2002;277:38503–38516.
   PubMed Web of Science ®Google Scholar
• Boullier A, Gillotte KL, Horkko S, Green SR, Friedman P, Dennis EA, Witztum JL, Steinberg D, Quehenberger O. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem 2000;275:9163–9169.
   PubMed Web of Science ®Google Scholar
• Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 2007;13:1086–1095.
   PubMed Web of Science ®Google Scholar
• Ashraf MZ, Kar NS, Chen X, Choi J, Salomon RG, Febbraio M, Podrez EA. Specific oxidized phospholipids inhibit scavenger receptor bi-mediated selective uptake of cholesteryl esters. J Biol Chem 2008;283:10408–10414.
   PubMed Web of Science ®Google Scholar
• Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000;69:419–445.
   PubMed Web of Science ®Google Scholar
• Walton KA, Hsieh X, Gharavi N, Wang S, Wang G, Yeh M, Cole AL, Berliner JA. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem 2003;278:29661–29666.
   PubMed Web of Science ®Google Scholar
• Furnkranz A, Schober A, Bochkov VN, Bashtrykov P, Kronke G, Kadl A, Binder BR, Weber C, Leitinger N. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler Thromb Vasc Biol 2005;25:633–638.
   PubMed Web of Science ®Google Scholar
• Kadl A, Galkina E, Leitinger N. Induction of CCR2- dependent macrophage accumulation by oxidized phospholipids in the air-pouch model of inflammation. Arthritis Rheum 2009;60:1362–1371.
   PubMedGoogle Scholar
• Bochkov VN, Mechtcheriakova D, Lucerna M, Huber J, Malli R, Graier WF, Hofer E, Binder BR, Leitinger N. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. Blood 2002;99:199–206.
   PubMed Web of Science ®Google Scholar
• Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, Nelson SF, Horvath S, Berliner JA, Kirchgessner TG, Lusis AJ. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci USA 2006;103:12741–12746.
   PubMed Web of Science ®Google Scholar
• de Assis EF, Silva AR, Caiado LF, Marathe GK, Zimmerman GA, Prescott SM, McIntyre TM, Bozza PT, de Castro-Faria-Neto HC. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes. J Immunol 2003;171:2090–2098.
   PubMed Web of Science ®Google Scholar
• Cherepanova OA, Pidkovka NA, Sarmento OF, Yoshida T, Gan Q, Adiguzel E, Bendeck MP, Berliner J, Leitinger N, Owens GK. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 2009;104:609–618.
   PubMed Web of Science ®Google Scholar
• Rouhanizadeh M, Hwang J, Clempus RE, Marcu L, Lassegue B, Sevanian A, Hsiai TK. Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic Biol Med 2005;39:1512–1522.
   PubMed Web of Science ®Google Scholar
• Lee S, Li R, Kim B, Palvolgyi R, Ho T, Yang QZ, Xu J, Szeto WL, Honda H, Berliner, JA. Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell. J Lipid Res 2009;50:265–274.
   PubMed Web of Science ®Google Scholar
• Oskolkova OV, Afonyushkin T, Leitner A, von Schlieffen E, Gargalovic PS, Lusis AJ, Binder BR, Bochkov VN. ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response. Blood 2008;112:330–339.
   PubMed Web of Science ®Google Scholar
• Chen R, Yang L, McIntyre TM. Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade. J Biol Chem 2007;282:24842–24850.
   PubMed Web of Science ®Google Scholar
• Fruhwirth GO, Hermetter A. Mediation of apoptosis by oxidized phospholipids. Subcell Biochem 2008;49:351–367.
   PubMedGoogle Scholar
• Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 2006;203:2613–2625.
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Tsironis LD, Tselepis AD. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol 2007;27:2094–2099.
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Witztum JL. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity. Curr Opin Lipidol 2008;19:369–377.
   PubMed Web of Science ®Google Scholar
• Frostegard J. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease. Clin Immunol 2010;134:47–54.
   PubMed Web of Science ®Google Scholar
• Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 1993;57:779S–785S; discussion 785S–786S.
   PubMed Web of Science ®Google Scholar
• Van Kuijk FJ, Holte LL, Dratz EA. 4-Hydroxyhexenal: a lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochim Biophys Acta 1990;1043:116–118.
   PubMed Web of Science ®Google Scholar
• Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 2003;419:31–40.
   PubMed Web of Science ®Google Scholar
• Kaunitz H, Johnson RE, Pegus L. A long term nutritional study with fresh and mildly oxidized vegetables and animal fats. J Am Oil Chem Soc 1965;42:770–774.
   Web of Science ®Google Scholar
• Yoshioka M, Kaneda T. Study on the toxicity of the autoxidized oil. III. The toxicity of hydroxyperoxyalkenals. Yukagaku 1974;23:321–326.
   Google Scholar
• Siu GM, Draper HH, Valli VE. Oral toxicity of malonaldehyde: a 90-day study on mice. J Toxicol Environ Health 1983;11:105–119.
   PubMed Web of Science ®Google Scholar
• Xanthis A, Hatzitolios A, Koliakos G, Tatola V. Advanced glycosylation end products and nutrition–a possible relation with diabetic atherosclerosis and how to prevent it. J Food Sci 2007;72:125–129.
   Web of Science ®Google Scholar
• Cai W, He JC, Zhu L, Chen X, Wallenstein S, Striker GE, Vlassara H. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol 2007;170:1893–1902.
   PubMed Web of Science ®Google Scholar
• Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000;28:1815–1826.
   PubMed Web of Science ®Google Scholar
• Steinbrecher UP. Receptors for oxidized low density lipoprotein. Biochim Biophys Acta 1999;1436:279–298.
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801–809.
   PubMed Web of Science ®Google Scholar
• Brown BE, Dean RT, Davies MJ. Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells. Diabetologia 2005;48:361–369.
   PubMed Web of Science ®Google Scholar
• Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004;37:937–945.
   PubMed Web of Science ®Google Scholar
• Vindis C, Escargueil-Blanc I, Elbaz M, Marcheix B, Grazide MH, Uchida K, Salvayre R, Negre-Salvayre A. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers. Circ Res 2006;98:785–792.
   PubMed Web of Science ®Google Scholar
• Suc I, Meilhac O, Lajoie-Mazenc I, Vandaele J, Jurgens G, Salvayre R, Negre-Salvayre A. Activation of EGF receptor by oxidized LDL. FASEB J 1998;12:665–671.
   PubMed Web of Science ®Google Scholar
• Escargueil-Blanc I, Salvayre R, Vacaresse N, Jurgens G, Darblade B, Arnal JF, Parthasarathy S, Negre-Salvayre A. Mildly oxidized LDL induces activation of platelet-derived growth factor beta-receptor pathway. Circulation 2001;104:1814–1821.
   PubMed Web of Science ®Google Scholar
• Liu W, Akhand AA, Kato M, Yokoyama I, Miyata T, Kurokawa K, Uchida K, Nakashima I. 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J Cell Sci 1999;112:2409–2417.
   PubMed Web of Science ®Google Scholar
• Portero-Otin M, Pamplona R, Bellmunt MJ, Ruiz MC, Prat, Salvayre R, Negre-Salvayre A. Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes 2002;51:1535–1542.
   PubMed Web of Science ®Google Scholar
• Cantero AV, Portero-Otin M, Ayala V, Auge N, Sanson M, Elbaz M, Thiers JC, Pamplona R, Salvayre R, Negre-Salvayre A. Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB J 2007;21:3096–3106.
   PubMed Web of Science ®Google Scholar
• Je JH, Lee JY, Jung KJ, Sung B, Go EK, Yu BP, Chung HY. NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway. FEBS Lett 2004;566:183–189.
   PubMed Web of Science ®Google Scholar
• Nitti M, Domenicotti C, d’Abramo C, Assereto S, Cottalasso D, Melloni E, Poli G, Biasi F, Marinari UM, Pronzato MA. Activation of PKC-beta isoforms mediates HNE-induced MCP-1 release by macrophages. Biochem Biophys Res Commun 2002;294:547–552.
   PubMed Web of Science ®Google Scholar
• Page S, Fischer C, Baumgartner B, Haas M, Kreusel U, Loidl G, Hayn M, Ziegler-Heitbrock HW, Neumeier D, Brand K. 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem 1999;274:11611–11618.
   PubMed Web of Science ®Google Scholar
• Donath B, Fischer C, Page S, Prebeck S, Jilg N, Weber M, da Costa C, Neumeier D, Miethke T, Brand K. Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure. Atherosclerosis 2002;165:79–88.
   PubMed Web of Science ®Google Scholar
• Valacchi G, Pagnin E, Phung A, Nardini M, Schock BC, Cross CE, van der Vliet A. Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid Redox Signal 2005;7:25–31.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Saito Y, Yoshida Y, Sekine A, Noguchi N, Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 2005;280:41921–41927.
   PubMed Web of Science ®Google Scholar
• Sanson M, Auge N, Vindis C, Muller C, Bando Y, Thiers JC, Marachet MA, Zarkovic K, Sawa Y, Salvayre R, Negre-Salvayre A. Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression. Circ Res 2009;104:328–336.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Gamba P, Sottero B, Kadl A, Robbesyn F, Calogero RA, Biasi F, Chiarpotto E, Leitinger N, Sevanian A, Poli G. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic Biol Med 2005;39:1152–1161.
   PubMed Web of Science ®Google Scholar
• Yang Y, Sharma R, Sharma A, Awasthi S, Awasthi YC. Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 2003;50:319–336.
   PubMed Web of Science ®Google Scholar
• Fukunaga M, Miyata S, Higo S, Hamada Y, Ueyama S, Kasuga M. Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells. Ann NY Acad Sci 2005;1043:151–157.
   PubMed Web of Science ®Google Scholar
• Chan WH, Wu HJ, Shiao NH. Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem 2007;100:1056–1069.
   PubMed Web of Science ®Google Scholar
• Kristal BS, Park BK, Yu BP. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J Biol Chem 1996;271:6033–6038.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Bertrand H, Yu BP. Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic Biol Med 1995;19:583–590.
   PubMed Web of Science ®Google Scholar
• Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-1376.
   PubMed Web of Science ®Google Scholar
• Torzewski M, Klouche M, Hock J, Messner M, Dorweiler B, Torzewski J, Gabbert HE, Bhakdi S. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol 1998;18:369–378.
   PubMed Web of Science ®Google Scholar
• Fredrikson GN, Berglund G, Alm R, Nilsson JA, Shah PK, Nilsson J. Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide. J Lipid Res 2006;47:2049–2054.
   PubMed Web of Science ®Google Scholar
• Tsimikas S. Oxidized low-density lipoprotein biomarkers in atherosclerosis. Curr Atheroscler Rep 2006;8:55–61.
   PubMedGoogle Scholar
• Fraley AE, Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol 2006;17:502–509.
   PubMed Web of Science ®Google Scholar
• Rong JX, Shen L, Chang YH, Richters A, Hodis HN, Sevanian A. Cholesterol oxidation products induce vascular foam cell lesion formation in hypercholesterolemic New Zealand white rabbits. Arterioscler Thromb Vasc Biol 1999;19:2179–2188.
   PubMed Web of Science ®Google Scholar
• Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res 1994;35:669–677.
   PubMed Web of Science ®Google Scholar
• Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999;142:1–28.
   PubMed Web of Science ®Google Scholar
• Poli G, Sottero B, Gargiulo S, Leonarduzzi G. Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. Mol Aspects Med 2009;30:180–189.
   PubMed Web of Science ®Google Scholar
• Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:1211–1217.
   PubMed Web of Science ®Google Scholar
• Lemaire S, Lizard G, Monier S, Miguet C, Gueldry S, Volot F, Gambert P, Neel D. Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett 1998;440:434–439.
   PubMed Web of Science ®Google Scholar
• Naito Y, Shimozawa M, Manabe H, Nakabe N, Katada K, Kokura S, Yoshida N, Ichikawa H, Kon T, Yoshikawa T. Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species. Eur J Pharmacol 2006;546:11–18.
   PubMed Web of Science ®Google Scholar
• Prunet C, Montange T, Vejux A, Laubriet A, Rohmer JF, Riedinger JM, Athias A, Lemaire-Ewing S, Neel D, Petit JM, Steinmetz E, Brenot R, Gambert P, Lizard G. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 2006;69:359–373.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Sevanian A, Sottero B, Arkan MC, Biasi F, Chiarpotto E, Basaga H, Poli G. Up-regulation of the fibrogenic cytokine TGF-beta1 by oxysterols: a mechanistic link between cholesterol and atherosclerosis. FASEB J 2001;15:1619–1621.
   PubMed Web of Science ®Google Scholar
• Adachi J, Ishii K, Tomita M, Fujita T, Nurhantari Y, Nagasaki Y, Ueno Y. Consecutive administration of paraquat to rats induces enhanced cholesterol peroxidation and lung injury. Arch Toxicol 2003;77:353–357.
   PubMed Web of Science ®Google Scholar
• Ferre N, Martinez-Clemente M, Lopez-Parra M, Gonzalez-Periz A, Horrillo R, Planaguma A, Camps J, Joven J, Tres A, Guardiola F, Bataller R, Arroyo V, Claria J. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. Am J Physiol Gastrointest Liver Physiol 2009;296:553–562.
   PubMed Web of Science ®Google Scholar
• Vejux A, Lizard G. Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med 2009;30:153–170.
   PubMed Web of Science ®Google Scholar
• Berthier A, Lemaire-Ewing S, Prunet C, Monier S, Athias A, Bessede G, Pais de Barros JP, Laubriet A, Gambert P, Lizard G, Neel D. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 2004;11:897–905.
   PubMed Web of Science ®Google Scholar
• Berthier A, Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Pais de Barros JP, Monier S, Gambert P, Lizard G, Neel D. 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. FEBS J 2005;272:3093–3104.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Gamba P, Gargiulo S, Sottero B, Kadl A, Biasi F, Chiarpotto E, Leitinger N, Vendemiale G, Serviddio G, Poli G. Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant oxysterol mixture. Aging Cell 2008;7:375–382.
   PubMed Web of Science ®Google Scholar
• Yun MR, Im DS, Lee SJ, Park HM, Bae SS, Lee WS, Kim CD. 4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase. Free Radic Biol Med 2009;46:692–698.
   PubMed Web of Science ®Google Scholar
• Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005;1:98–114; quiz 120.
   PubMedGoogle Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–1594.
   PubMed Web of Science ®Google Scholar
• Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N, Jr, Rice RJ. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 1996;87:557–563.
   PubMed Web of Science ®Google Scholar
• Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979–1986. Am J Obstet Gynecol 1990;163:460–465.
   PubMed Web of Science ®Google Scholar
• MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001;97:533–538.
   PubMed Web of Science ®Google Scholar
• Paruk F, Moodley J. Maternal and neonatal outcome in early- and late-onset pre-eclampsia. Semin Neonatol 2000;5:197–207.
   PubMedGoogle Scholar
• Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30(Suppl A):38–42.
   Google Scholar
• Webster RP, Roberts VH, Myatt L. Protein nitration in placenta - functional significance. Placenta 2008;29:985–994.
   PubMed Web of Science ®Google Scholar
• Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010;31(Suppl):66–69.
   Google Scholar
• Chekir C, Nakatsuka M, Noguchi S, Konishi H, Kamada Y, Sasaki A, Hao L, Hiramatsu Y. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta 2006;27:225–233.
   PubMed Web of Science ®Google Scholar
• Uchida K. Lipid peroxidation and redox-sensitive signaling pathways. Curr Atheroscler Rep 2007;9:216–221.
   PubMedGoogle Scholar
• Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 2005;49:1063–1071.
   PubMed Web of Science ®Google Scholar
• Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, Afonyushkin T, Gruber F, Breuss J, Minchenko A, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Erne P, Binder BR, Leitinger N. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ Res 2006;99:900–908.
   PubMed Web of Science ®Google Scholar
• Mahdy Z, Otun HA, Dunlop W, Gillespie JI. The responsiveness of isolated human hand vein endothelial cells in normal pregnancy and in pre-eclampsia. J Physiol 1998;508:609–617.
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer IA. Pre-eclampsia: a multifaceted vascular disorder of pregnancy. J Hypertens 1994;12:1339–1345.
   PubMed Web of Science ®Google Scholar
• Poston L. Maternal vascular function in pregnancy. J Hum Hypertens 1996;10:391–394.
   PubMed Web of Science ®Google Scholar
• Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003;361:1511–1517.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–658.
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642–649.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992–1005.
   PubMed Web of Science ®Google Scholar
• Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007;115:1789–1797.
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173–192.
   PubMed Web of Science ®Google Scholar
• Mills TA, Wareing M, Shennan AH, Poston L, Baker PN, Greenwood SL. Acute and chronic modulation of placental chorionic plate artery reactivity by reactive oxygen species. Free Radic Biol Med 2009;47:159–166.
   PubMed Web of Science ®Google Scholar
• Trudinger BJ, Giles WB, Cook CM. Flow velocity waveforms in the maternal uteroplacental and fetal umbilical placental circulations. Am J Obstet Gynecol 1985;152:155–163.
   PubMed Web of Science ®Google Scholar
• Rayman MP, Barlis J, Evans RW, Redman CW, King LJ. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol 2002;187:412–418.
   PubMed Web of Science ®Google Scholar
• Gupta S, Aziz N, Sekhon L, Agarwal R, Mansour G, Li J, Agarwal A. Lipid peroxidation and antioxidant status in preeclampsia: a systematic review. Obstet Gynecol Surv 2009;64:750–759.
   PubMed Web of Science ®Google Scholar
• Hnat MD, Meadows JW, Brockman DE, Pitzer B, Lyall F, Myatt L. Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, preeclamptic and intrauterine growth restricted pregnancies. Am J Obstet Gynecol 2005;193:836–840.
   PubMed Web of Science ®Google Scholar
• Rudra CB, Qiu C, David RM, Bralley JA, Walsh SW, Williams MA. A prospective study of early-pregnancy plasma malondialdehyde concentration and risk of preeclampsia. Clin Biochem 2006;39:722–726.
   PubMed Web of Science ®Google Scholar
• Mistry HD, Wilson V, Ramsay MM, Symonds ME, Broughton Pipkin F. Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension 2008;52:881–888.
   PubMed Web of Science ®Google Scholar
• Mehendale S, Kilari A, Dangat K, Taralekar V, Mahadik S, Joshi S. Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int J Gynaecol Obstet 2008;100:234–238.
   PubMed Web of Science ®Google Scholar
• Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 2008;313:37–44.
   PubMed Web of Science ®Google Scholar
• Biri A, Bozkurt N, Gunaydin G, Korucuoglu U, Durak I, Kavutcu M. Antioxidant enzyme activities and lipid peroxidation in preeclampsia. Int J Gynaecol Obstet 2007;96:196–197.
   PubMed Web of Science ®Google Scholar
• Chamy VM, Lepe J, Catalan A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res 2006;39:229–236.
   PubMed Web of Science ®Google Scholar
• Balogh LM, Roberts AG, Shireman LM, Greene RJ, Atkins WM. The stereochemical course of 4-hydroxy-2-nonenal metabolism by glutathione S-transferases. J Biol Chem 2008;283:16702–16710.
   PubMed Web of Science ®Google Scholar
• Awasthi YC, Yang Y, Tiwari NK, Patrick B, Sharma A, Li J, Awasthi S. Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic Biol Med 2004;37:607–619.
   PubMed Web of Science ®Google Scholar
• Rayman MP, Bode P, Redman CW. Low selenium status is associated with the occurrence of the pregnancy disease preeclampsia in women from the United Kingdom. Am J Obstet Gynecol 2003;189:1343–1349.
   PubMed Web of Science ®Google Scholar
• Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007;43:4–15.
   PubMed Web of Science ®Google Scholar
• Atkinson J, Harroun T, Wassall SR, Stillwell W, Katsaras J. The location and behavior of alpha-tocopherol in membranes. Mol Nutr Food Res 2010;54:641–651.
   PubMed Web of Science ®Google Scholar
• Serdar Z, Gur E, Colakoethullary M, Develioethlu O, Sarandol E. Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch Gynecol Obstet 2003;268:19–25.
   PubMedGoogle Scholar
• Gratacos E, Casals E, Deulofeu R, Cararach V, Alonso PL, Fortuny A. Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. Am J Obstet Gynecol 1998;178:1072–1076.
   PubMed Web of Science ®Google Scholar
• Llurba E, Gratacos E, Martin-Gallan P, Cabero L, Dominguez CA comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004;37:557–570.
   PubMed Web of Science ®Google Scholar
• El-Salahy EM, Ahmed MI, El-Gharieb A, Tawfik H. New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females. Clin Biochem 2001;34:323–329.
   PubMed Web of Science ®Google Scholar
• Yanik FF, Amanvermez R, Yanik A, Celik C, Kokcu A. Pre-eclampsia associated with increased lipid peroxidation and decreased serum vitamin E levels. Int J Gynaecol Obstet 1999;64:27–33.
   PubMed Web of Science ®Google Scholar
• Ishihara O, Hayashi M, Osawa H, Kobayashi K, Takeda S, Vessby B, Basu S. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy. Free Radic Res 2004;38:913–918.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim CH, Cho MK, Kim KM, Lee SY, Ahn BW, Yang SY, Kim SM, Song TB. Total peroxyl radical-trapping ability and anti-oxidant vitamins of the umbilical venous plasma and the placenta in pre-eclampsia. J Obstet Gynaecol Res 2006;32:32–41.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Edep ME, Goldfien A, Taylor RN. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol 1992;27:101–108.
   PubMed Web of Science ®Google Scholar
• Robinson NJ, Minchell LJ, Myers JE, Hubel CA, Crocker IP. A potential role for free fatty acids in the pathogenesis of preeclampsia. J Hypertens 2009;27:1293–1302.
   PubMed Web of Science ®Google Scholar
• Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 2001;15:279–281.
   PubMed Web of Science ®Google Scholar
• Scalera F, Fischer T, Schlembach D, Beinder E. Serum from healthy pregnant women reduces oxidative stress in human umbilical vein endothelial cells. Clin Sci (Lond) 2002;103:53–57.
   PubMed Web of Science ®Google Scholar
• Herbst U, Toborek M, Kaiser S, Mattson MP, Hennig B. 4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells. J Cell Physiol 1999;181:295–303.
   PubMed Web of Science ®Google Scholar
• Tastekin A, Ors R, Demircan B, Saricam Z, Ingec M, Akcay F. Oxidative stress in infants born to preeclamptic mothers. Pediatr Int 2005;47:658–662.
   PubMed Web of Science ®Google Scholar
• Braekke K, Harsem NK, Staff AC. Oxidative stress and antioxidant status in fetal circulation in preeclampsia. Pediatr Res 2006;60:560–564.
   PubMed Web of Science ®Google Scholar
• Howlader MZ, Parveen S, Tamanna S, Khan TA, Begum F. Oxidative stress and antioxidant status in neonates born to pre-eclamptic mother. J Trop Pediatr 2009;55:363–367.
   PubMed Web of Science ®Google Scholar
• Gitto E, Pellegrino S, Gitto P, Barberi I, Reiter RJ. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009;46:128–139.
   PubMed Web of Science ®Google Scholar
• Steinert JR, Wyatt AW, Jacob R, Mann GE. Redox modulation of Ca2+ signaling in human endothelial and smooth muscle cells in pre-eclampsia. Antioxid Redox Signal 2009;11:1149–1163.
   PubMed Web of Science ®Google Scholar
• Romanowicz L, Bankowski E. Lipid compounds of the umbilical cord artery and their alterations in preeclampsia. Atherosclerosis 2009;204:44–51.
   Google Scholar
• Barker DJ. Fetal origins of coronary heart disease. BMJ 1995;311:171–174.
   PubMed Web of Science ®Google Scholar
• Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002;13:364–368.
   PubMed Web of Science ®Google Scholar
• Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938–941.
   PubMed Web of Science ®Google Scholar
• Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J 2002;16:1348–1360.
   PubMed Web of Science ®Google Scholar
• Myatt L. Placental adaptive responses and fetal programming. J Physiol 2006;572:25–30.
   PubMed Web of Science ®Google Scholar
• Steinert JR, Poston L, Mann GE, Jacob R. Abnormalities in intracellular Ca2+ regulation in fetal vascular smooth muscle in pre-eclampsia: enhanced sensitivity to arachidonic acid. FASEB J 2003;17:307–309.
   PubMedGoogle Scholar
• Steinert JR, Wyatt AW, Poston L, Jacob R, Mann GE. Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells. FASEB J 2002;16:721–723.
   PubMed Web of Science ®Google Scholar
• Akar F, Ark M, Uydes BS, Soysal ME, Saracoglu F, Abacioglu N, Van de Voorde J, Kanzik I. Nitric oxide production by human umbilical vessels in severe pre-eclampsia. J Hypertens 1994;12:1235–1241.
   PubMed Web of Science ®Google Scholar
• Seidman DS, Laor A, Gale R, Stevenson DK, Mashiach S, Danon YL. Pre-eclampsia and offspring's blood pressure, cognitive ability and physical development at 17-years-of-age. Br J Obstet Gynaecol 1991;98:1009–1014.
   PubMedGoogle Scholar
• Tenhola S, Rahiala E, Halonen P, Vanninen E, Voutilainen R. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res 2006;59:320–324.
   PubMed Web of Science ®Google Scholar
• Tenhola S, Rahiala E, Martikainen A, Halonen P, Voutilainen R. Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. J Clin Endocrinol Metab 2003;88:1217–1222.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Romundstad PR, Holmen TL, Hsieh CC, Trichopoulos D, Stuver SO. Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet Gynecol 2003;101:529–533.
   PubMed Web of Science ®Google Scholar
• Oglaend B, Forman MR, Romundstad PR, Nilsen ST, Vatten LJ. Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies. J Hypertens 2009;27:2051–2054.
   PubMed Web of Science ®Google Scholar
• Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009;40:1176–1180.
   PubMed Web of Science ®Google Scholar
• Ferreira I, Peeters LL, Stehouwer CD. Preeclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. J Hypertens 2009;27:1955–1959.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
   PubMed Web of Science ®Google Scholar
• Afzal-Ahmed I, Mann GE, Shennan AH, Poston L, Naftalin RJ. Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. Free Radic Biol Med 2007;42:1781–1790.
   PubMed Web of Science ®Google Scholar
• Sobrevia L, Cesare P, Yudilevich DL, Mann GE. Diabetes-induced activation of system y+ and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol 1995;489:183–192.
   PubMed Web of Science ®Google Scholar
• Sobrevia L, Yudilevich DL, Mann GE. Elevated D-glucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies. J Physiol 1998;506:219–230.
   PubMed Web of Science ®Google Scholar
• Casanello P, Sobrevia L. Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+/hCAT-1 and y+/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells. Circ Res 2002;91:127–134.
   PubMed Web of Science ®Google Scholar
• Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001;344:867–872.
   PubMed Web of Science ®Google Scholar
• Lodovici M, Bigagli E, Bardini G, Rotella CM. Lipoperoxidation and antioxidant capacity in patients with poorly controlled type 2 diabetes. Toxicol Ind Health 2009;25:337–341.
   PubMed Web of Science ®Google Scholar
• Goodarzi MT, Varmaziar L, Navidi AA, Parivar K. Study of oxidative stress in type 2 diabetic patients and its relationship with glycated hemoglobin. Saudi Med J 2008;29:503–506.
   PubMed Web of Science ®Google Scholar
• Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008;45:41–46.
   PubMed Web of Science ®Google Scholar
• Ahmed FN, Naqvi FN, Shafiq F. Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus. Ann NY Acad Sci 2006;1084:481–489.
   PubMed Web of Science ®Google Scholar
• Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem 2001;34:65–70.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Salvayre R, Auge N, Pamplona R, Portero-Otin M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 2009;11:3071–3109.
   PubMed Web of Science ®Google Scholar
• Han Y, Randell E, Vasdev S, Gill V, Gadag V, Newhook LA, Grant M, Hagerty D. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Mol Cell Biochem 2007;305:123–131.
   PubMed Web of Science ®Google Scholar
• Oranje WA, Rondas-Colbers GJ, Swennen GN, Wolffenbuttel BH. Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease? Neth J Med 1998;53:61–68.
   PubMed Web of Science ®Google Scholar
• Selvaraj N, Bobby Z, Koner BC, Das AK. Reassessing the increased glycation of hemoglobin in nondiabetic chronic renal failure patients: a hypothesis on the role of lipid peroxides. Clin Chim Acta 2005;360:108–113.
   PubMed Web of Science ®Google Scholar
• Mezzetti A, Cipollone F, Cuccurullo F. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res 2000;47:475–488.
   PubMed Web of Science ®Google Scholar
• Inouye M, Mio T, Sumino K. Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients. Metabolism 1999;48:205–209.
   PubMed Web of Science ®Google Scholar
• Inouye M, Hashimoto H, Mio T, Sumino K. Levels of lipid peroxidation product and glycated hemoglobin A1c in the erythrocytes of diabetic patients. Clin Chim Acta 1998;276:163–172.
   PubMed Web of Science ®Google Scholar
• Weng SW, Lin TK, Liou CW, Chen SD, Wei YH, Lee HC, Chen IY, Hsieh CJ, Wang PW. Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism. Diabetes Res Clin Pract 2009;83:94–99.
   PubMed Web of Science ®Google Scholar
• Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004;53:2079–2086.
   PubMed Web of Science ®Google Scholar
• Lee DM, Hoffman WH, Carl GF, Khichi M, Cornwell PE. Lipid peroxidation and antioxidant vitamins prior to, during, and after correction of diabetic ketoacidosis. J Diabetes Complications 2002;16:294–300.
   PubMed Web of Science ®Google Scholar
• Peuchant E, Delmas-Beauvieux MC, Couchouron A, Dubourg L, Thomas MJ, Perromat A, Clerc M, Gin H. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 1997;20:202–207.
   PubMed Web of Science ®Google Scholar
• Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH, Mueller M, Horvath T, Doerries C, Heinemann M, Flemmer S, Markowski A, Manes C, Bahr MJ, Haller H, von Eckardstein A, Drexler H, Landmesser U. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2010;121:110–122.
   PubMed Web of Science ®Google Scholar
• Davison GW, Ashton T, George L, Young IS, McEneny J, Davies B, Jackson SK, Peters JR, Bailey DM. Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: a randomised controlled trial. Diabetologia 2008;51:2049–2059.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Evans ML, Ellis GR, Graham J, Morris K, Jackson SK, Lewis MJ, Rees A, Frenneaux MP. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis 2001;154:475–483.
   PubMed Web of Science ®Google Scholar
• Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 1989;264:21340–21345.
   PubMed Web of Science ®Google Scholar
• Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989;38:1539–1543.
   PubMed Web of Science ®Google Scholar
• Gillery P, Monboisse JC, Maquart FX, Borel JP. Glycation of proteins as a source of superoxide. Diabete Metab 1988;14:25–30.
   PubMed Web of Science ®Google Scholar
• Hunt JV, Smith CC, Wolff SP. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990;39:1420–1424.
   PubMed Web of Science ®Google Scholar
• Serin O, Konukoglu D, Firtina S, Mavis O. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test. Horm Metab Res 2007;39:207–211.
   PubMed Web of Science ®Google Scholar
• Manuel YKB, de Vos C, van Campenhout A, Vinckx M, Abrams P, van Campenhout C. Divergent in vitro and in vivo lipid peroxidation in the postprandial phase of patients with type I diabetes mellitus. Eur J Clin Nutr 2008;62:401–410.
   PubMed Web of Science ®Google Scholar
• Hu Y, Block G, Norkus EP, Morrow JD, Dietrich M, Hudes M. Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr 2006;84:70–76; quiz 266–267.
   PubMed Web of Science ®Google Scholar
• Ohmura C, Watada H, Azuma K, Shimizu T, Kanazawa A, Ikeda F, Yoshihara T, Fujitani Y, Hirose T, Tanaka Y, Kawamori R. Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes. Endocr J 2009;56:149–156.
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787–790.
   PubMed Web of Science ®Google Scholar
• Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M. Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 2003;112:1049–1057.
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615–1625.
   PubMed Web of Science ®Google Scholar
• Schrauwen P, Schrauwen-Hinderling V, Hoeks J, Hesselink MK. Mitochondrial dysfunction and lipotoxicity. Biochim Biophys Acta 2010;1801:266–271.
   PubMed Web of Science ®Google Scholar
• Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Moonen-Kornips E, Schaart G, Mustard KJ, Hardie DG, Saris WH, Nicolay K, Schrauwen P. Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes Res 2005;13:2088–2094.
   PubMedGoogle Scholar
• Raubenheimer PJ. Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:2419–2421; author reply 2419–2421.
   PubMedGoogle Scholar
• Short KR, Nair KS, Stump CS. Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:2419–2421; author reply 2419–2421.
   PubMedGoogle Scholar
• Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140–1142.
   PubMed Web of Science ®Google Scholar
• Richardson DK, Kashyap S, Bajaj M, Cusi K, Mandarino SJ, Finlayson J, DeFronzo RA, Jenkinson CP, Mandarino LJ. Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 2005;280:10290–10297.
   PubMed Web of Science ®Google Scholar
• Schrauwen P, Mensink M, Schaart G, Moonen-Kornips E, Sels JP, Blaak EE, Russell AP, Hesselink MK. Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment. J Clin Endocrinol Metab 2006;91:1520–1525.
   Web of Science ®Google Scholar
• Boveris A, Cadenas E. Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone. IUBMB Life 2000;50:245–250.
   PubMed Web of Science ®Google Scholar
• Herrero A, Barja G. Localization of the site of oxygen radical generation inside the complex I of heart and nonsynaptic brain mammalian mitochondria. J Bioenerg Biomembr 2000;32:609–615.
   PubMed Web of Science ®Google Scholar
• Barja G, Herrero A. Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J Bioenerg Biomembr 1998;30:235–243.
   PubMed Web of Science ®Google Scholar
• Genova ML, Ventura B, Giuliano G, Bovina C, Formiggini G, Parenti Castelli G, Lenaz G. The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2. FEBS Lett 2001;505:364–368.
   PubMed Web of Science ®Google Scholar
• Ho JK, Duclos RI, Jr, Hamilton JA. Interactions of acyl carnitines with model membranes: a (13)C-NMR study. J Lipid Res 2002;43:1429–1439.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Negative consequences of glycation. Metabolism 2000;49:9–13.
   PubMed Web of Science ®Google Scholar
• Nathan DM. Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study. Lancet 1998;352:832–833.
   PubMed Web of Science ®Google Scholar
• Russell AP, Gastaldi G, Bobbioni-Harsch E, Arboit P, Gobelet C, Deriaz O, Golay A, Witztum JL, Giacobino JP. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett 2003;551:104–106.
   PubMed Web of Science ®Google Scholar
• Hulbert AJ, Pamplona R, Buffenstein R, Buttemer WA. Life and death: metabolic rate, membrane composition, and life span of animals. Physiol Rev 2007;87:1175–1213.
   PubMed Web of Science ®Google Scholar
• Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H, Rieusset J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 2008;118:789–800.
   PubMed Web of Science ®Google Scholar
• Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 1997;416:15–18.
   PubMed Web of Science ®Google Scholar
• Amara CE, Shankland EG, Jubrias SA, Marcinek DJ, Kushmerick MJ, Conley KE. Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo. Proc Natl Acad Sci USA 2007;104:1057–1062.
   PubMed Web of Science ®Google Scholar
• Borst P, Loos JA, Christ EJ, Slater EC. Uncoupling activity of long-chain fatty acids. Biochim Biophys Acta 1962;62:509–518.
   PubMed Web of Science ®Google Scholar
• Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin M, Pamplona R, Vidal-Puig AJ, Wang S, Roebuck SJ, Brand MD. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 2003;22:4103–4110.
   PubMed Web of Science ®Google Scholar
• Portero-Otin M, Pamplona R, Boada J, Jove M, Gonzalo H, Buleon M, Linz W, Schafer S, Tack I, Girolami JP. Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats. Biochem Biophys Res Commun 2008;368:528–535.
   PubMed Web of Science ®Google Scholar
• Goglia F, Skulachev VP. A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. FASEB J 2003;17:1585–1591.
   PubMed Web of Science ®Google Scholar
• Brand MD, Pamplona R, Portero-Otin M, Requena JR, Roebuck SJ, Buckingham JA, Clapham JC, Cadenas S. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem J 2002;368:597–603.
   PubMed Web of Science ®Google Scholar
• Hoeks J, Hesselink MK, Sluiter W, Schaart G, Willems J, Morrisson A, Clapham JC, Saris WH, Schrauwen P. The effect of high-fat feeding on intramuscular lipid and lipid peroxidation levels in UCP3-ablated mice. FEBS Lett 2006;580:1371–1375.
   PubMed Web of Science ®Google Scholar
• Schrauwen P, Hesselink MK, Blaak EE, Borghouts LB, Schaart G, Saris WH, Keizer HA. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2001;50:2870–2873.
   PubMed Web of Science ®Google Scholar
• Bryant RW, Bailey JM. Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium-deficient rats. Biochem Biophys Res Commun 1980;92:268–276.
   PubMed Web of Science ®Google Scholar
• Bacot S, Bernoud-Hubac N, Chantegrel B, Deshayes C, Doutheau A, Ponsin G, Lagarde M, Guichardant M. Evidence for in situ ethanolamine phospholipid adducts with hydroxyalkenals. J Lipid Res 2007;48:816–825.
   PubMed Web of Science ®Google Scholar
• Guichardant M, Bernoud-Hubac N, Chantegrel B, Deshayes C, Lagarde M. Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot Essent Fatty Acids 2002;67:147–149.
   PubMed Web of Science ®Google Scholar
• Bacot S, Bernoud-Hubac N, Baddas N, Chantegrel B, Deshayes C, Doutheau A, Lagarde M, Guichardant M. Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses. J Lipid Res 2003;44:917–926.
   PubMed Web of Science ®Google Scholar
• Riahi Y, Sin-Malia Y, Cohen G, Alpert E, Gruzman A, Eckel J, Staels B, Guichardant M, Sasson S. The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal (4-HDDE) and PPAR{delta}. Diabetes 2010;59:808–818.
   PubMed Web of Science ®Google Scholar
• Schneider C. An update on products and mechanisms of lipid peroxidation. Mol Nutr Food Res 2009;53:315–321.
   PubMed Web of Science ®Google Scholar
• Schneider C, Porter NA, Brash AR. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J Biol Chem 2008;283:15539–15543.
   PubMed Web of Science ®Google Scholar
• Tejero I, Gonzalez-Lafont A, Lluch JM, Eriksson LA. Theoretical modeling of hydroxyl-radical-induced lipid peroxidation reactions. J Phys Chem B 2007;111:5684–5693.
   PubMed Web of Science ®Google Scholar
• Carini M, Aldini G, Facino RM. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrom Rev 2004;23:281–305.
   PubMed Web of Science ®Google Scholar
• Gardner HW, Hamberg M. Oxygenation of (3Z)-nonenal to (2E)-4-hydroxy-2-nonenal in the broad bean (Vicia faba L.). J Biol Chem 1993;268:6971–6977.
   PubMed Web of Science ®Google Scholar
• Pryor WA, Porter NA. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic Biol Med 1990;8:541–543.
   PubMed Web of Science ®Google Scholar
• Guichardant M, Bacot S, Moliere P, Lagarde M. Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot Essent Fatty Acids 2006;75:179–182.
   PubMed Web of Science ®Google Scholar
• Coleman JD, Prabhu KS, Thompson JT, Reddy PS, Peters JM, Peterson BR, Reddy CC, Vanden Heuvel JP. The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Free Radic Biol Med 2007;42:1155–1164.
   PubMed Web of Science ®Google Scholar
• Alpert E, Gruzman A, Riahi Y, Blejter R, Aharoni P, Weisinger G, Eckel J, Kaiser N, Sasson S. Delayed autoregulation of glucose transport in vascular endothelial cells. Diabetologia 2005;48:752–755.
   PubMed Web of Science ®Google Scholar
• Alpert E, Gruzman A, Totary H, Kaiser N, Reich R, Sasson S. A natural protective mechanism against hyperglycaemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid. Biochem J 2002;362:413–422.
   PubMed Web of Science ®Google Scholar
• Patricia MK, Kim JA, Harper CM, Shih PT, Berliner JA, Natarajan R, Nadler JL, Hedrick CC. Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells. Arterioscler Thromb Vasc Biol 1999;19:2615–2622.
   PubMed Web of Science ®Google Scholar
• Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest 1999;103:1431–1436.
   PubMed Web of Science ®Google Scholar
• Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003;42:318–343.
   PubMed Web of Science ®Google Scholar
• Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Thorpe SR. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant 1996;11(Suppl 5):48–53.
   PubMed Web of Science ®Google Scholar
• Eckl PM, Ortner A, Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat Res 1993;290:183–192.
   PubMed Web of Science ®Google Scholar
• Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 1995;44:1447–1457.
   PubMed Web of Science ®Google Scholar
• Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC. Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 2002;277:10912–10921.
   PubMed Web of Science ®Google Scholar
• Natarajan R, Gu JL, Rossi J, Gonzales N, Lanting L, Xu L, Nadler J. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci USA 1993;90:4947–4951.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Yamada S, Kashima M, Ihara Y, Yamada Y, Tanaka T, Hiai H, Seino Y, Uchida K. Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid Redox Signal 2000;2:681–685.
   PubMed Web of Science ®Google Scholar
• Orioli M, Aldini G, Benfatto MC, Facino RM, Carini M. HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS/MS profiling in Zucker obese rats. Anal Chem 2007;79:9174–9184.
   PubMed Web of Science ®Google Scholar
• Bleich D, Chen S, Gu JL, Nadler JL. The role of 12-lipoxygenase in pancreatic - cells (Review). Int J Mol Med 1998;1:265–272.
   PubMed Web of Science ®Google Scholar
• Prasad KM, Thimmalapura PR, Woode EA, Nadler JL. Evidence that increased 12-lipoxygenase expression impairs pancreatic beta cell function and viability. Biochem Biophys Res Commun 2003;308:427–432.
   PubMed Web of Science ®Google Scholar
• Miwa I, Ichimura N, Sugiura M, Hamada Y, Taniguchi S. Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology 2000;141:2767–2772.
   PubMed Web of Science ®Google Scholar
• Nunemaker CS, Chen M, Pei H, Kimble SD, Keller SR, Carter JD, Yang Z, Smith KM, Wu R, Bevard MH, Garmey JC, Nadler JL. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Am J Physiol Endocrinol Metab 2008;295:1065–1075.
   PubMed Web of Science ®Google Scholar
• Chen M, Yang ZD, Smith KM, Carter JD, Nadler JL. Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity. Diabetologia 2005;48:486–495.
   PubMed Web of Science ®Google Scholar
• Barrera G, Pizzimenti S, Laurora S, Briatore F, Toaldo C, Dianzani MU. 4-hydroxynonenal and cell cycle. Biofactors 2005;24:151–157.
   PubMed Web of Science ®Google Scholar
• McDuffie M, Maybee NA, Keller SR, Stevens BK, Garmey JC, Morris MA, Kropf E, Rival C, Ma K, Carter JD, Tersey SA, Nunemaker CS, Nadler JL. Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes. Diabetes 2008;57:199–208.
   PubMed Web of Science ®Google Scholar
• Suarez-Pinzon WL, Strynadka K, Rabinovitch A. Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes. Endocrinology 1996;137:5290–5296.
   PubMed Web of Science ®Google Scholar
• Numazawa S, Sakaguchi H, Aoki R, Taira T, Yoshida T. Regulation of the susceptibility to oxidative stress by cysteine availability in pancreatic beta-cells. Am J Physiol Cell Physiol 2008;295:468–474.
   Web of Science ®Google Scholar
• Cahuana GM, Tejedo JR, Jimenez J, Ramirez R, Sobrino F, Bedoya FJ. Involvement of advanced lipooxidation end products (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells. Biochem Pharmacol 2003;66:1963–1971.
   Google Scholar
• Srivastava S, Chandra A, Wang LF, Seifert WE, Jr, DaGue BB, Ansari NH, Srivastava SK, Bhatnagar A. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem 1998;273:10893–10900.
   PubMed Web of Science ®Google Scholar
• Murphy TC, Poppe C, Porter JE, Montine TJ, Picklo MJ, Sr. 4-Hydroxy-trans-2-nonenoic acid is a gamma-hydroxybutyrate receptor ligand in the cerebral cortex and hippocampus. J Neurochem 2004;89:1462–1470.
   PubMed Web of Science ®Google Scholar
• Kaiser N, Leibowitz G. Failure of beta-cell adaptation in type 2 diabetes: lessons from animal models. Front Biosci 2009;14:1099–1115.
   Web of Science ®Google Scholar
• Modak MA, Parab PB, Ghaskadbi SS. Pancreatic islets are very poor in rectifying oxidative DNA damage. Pancreas 2009;38:23–29.
   PubMed Web of Science ®Google Scholar
• Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996;20:463–466.
   PubMed Web of Science ®Google Scholar
• Wu L, Nicholson W, Knobel SM, Steffner RJ, May JM, Piston DW, Powers AC. Oxidative stress is a mediator of glucose toxicity in insulin-secreting pancreatic islet cell lines. J Biol Chem 2004;279:12126–12134.
   PubMed Web of Science ®Google Scholar
• Traverso N, Menini S, Odetti P, Pronzato MA, Cottalasso D, Marinari UM. Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic Biol Med 2002;32:350–359.
   PubMed Web of Science ®Google Scholar
• Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 2008;31(Suppl 2):155–160.
   Google Scholar
• Yu Y, Lyons TJ. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am J Med Sci 2005;330:227–232.
   PubMed Web of Science ®Google Scholar
• Yamagishi SI, Nakamura K, Matsui T, Ueda SI, Imaizumi T. Role of postprandial hyperglycaemia in cardiovascular disease in diabetes. Int J Clin Pract 2007;61:83–87.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–412.
   PubMed Web of Science ®Google Scholar
• Minekura H, Kumagai T, Kawamoto Y, Nara F, Uchida K. 4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochem Biophys Res Commun 2001;282:557–561.
   PubMed Web of Science ®Google Scholar
• Whitsett J, Picklo MJ, Sr, Vasquez-Vivar J. 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol 2007;27:2340–2347.
   PubMed Web of Science ®Google Scholar
• Yun MR, Im DS, Lee SJ, Woo JW, Hong KW, Bae SS, Kim CD. 4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class A scavenger receptor at the level of translation. Free Radic Biol Med 2008;45:177–183.
   PubMed Web of Science ®Google Scholar
• Annangudi SP, Deng Y, Gu X, Zhang W, Crabb JW, Salomon RG. Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE. Chem Res Toxicol 2008;21:1384–1395.
   PubMed Web of Science ®Google Scholar
• Kakishita H, Hattori Y. Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sci 2001;69:689–697.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Pakala R, Katagiri T, Benedict CR. Oxidized low-density lipoproteins potentiate the mitogenic effect of 5-hydroxytryptamine on vascular smooth muscle cells. Jpn Heart J 2002;43:35–42.
   PubMedGoogle Scholar
• Ramana KV, Bhatnagar A, Srivastava S, Yadav UC, Awasthi S, Awasthi YC, Srivastava SK. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J Biol Chem 2006;281:17652–17660.
   PubMed Web of Science ®Google Scholar
• Lee JY, Jung GY, Heo HJ, Yun MR, Park JY, Bae SS, Hong KW, Lee WS, Kim CD. 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicol Lett 2006;166:212–221.
   PubMed Web of Science ®Google Scholar
• Hill BG, Haberzettl P, Ahmed Y, Srivastava S, Bhatnagar A. Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochem J 2008;410:525–534.
   PubMed Web of Science ®Google Scholar
• Li WG, Stoll LL, Rice JB, Xu SP, Miller FJ, Jr, Chatterjee P, Hu L, Oberley LW, Spector AA, Weintraub NL. Activation of NAD(P)H oxidase by lipid hydroperoxides: mechanism of oxidant-mediated smooth muscle cytotoxicity. Free Radic Biol Med 2003;34:937–946.
   PubMed Web of Science ®Google Scholar
• Akiba S, Kumazawa S, Yamaguchi H, Hontani N, Matsumoto T, Ikeda T, Oka M, Sato T. Acceleration of matrix metalloproteinase-1 production and activation of platelet-derived growth factor receptor beta in human coronary smooth muscle cells by oxidized LDL and 4-hydroxynonenal. Biochim Biophys Acta 2006;1763:797–804.
   PubMed Web of Science ®Google Scholar
• Vindis C, Escargueil-Blanc I, Uchida K, Elbaz M, Salvayre R, Negre-Salvayre A. Lipid oxidation products and oxidized low-density lipoproteins impair platelet-derived growth factor receptor activity in smooth muscle cells: implication in atherosclerosis. Redox Rep 2007;12:96–100.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Seo KW, Yun MR, Bae SS, Lee WS, Hong KW, Kim CD. 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways. Free Radic Biol Med 2008;45:1487–1492.
   PubMed Web of Science ®Google Scholar
• Seo KW, Lee SJ, Kim CE, Yun MR, Park HM, Yun JW, Bae SS, Kim CD. Participation of 5-lipoxygenase-derived LTB(4) in 4-hydroxynonenal-enhanced MMP-2 production in vascular smooth muscle cells. Atherosclerosis 2010;208:56–61.
   PubMed Web of Science ®Google Scholar
• Yamanouchi J, Takatori A, Itagaki S, Kawamura S, Yoshikawa Y. APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins. Exp Anim 2000;49:267–274.
   PubMed Web of Science ®Google Scholar
• Meng J, Sakata N, Takebayashi S, Asano T, Futata T, Nagai R, Ikeda K, Horiuchi S, Myint T, Taniguchi N. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage. Atherosclerosis 1998;136:355–365.
   PubMed Web of Science ®Google Scholar
• Polak M, Zagorski Z. Lipid peroxidation in diabetic retinopathy. Ann Univ Mariae Curie Sklodowska Med 2004;59:434–437.
   PubMedGoogle Scholar
• Furfaro AL, Menini S, Patriarca S, Pesce C, Odetti P, Cottalasso D, Marinari UM, Pronzato MA, Traverso N. HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin. Biofactors 2005;24:291–298.
   PubMed Web of Science ®Google Scholar
• Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de Strihou C, Monnier VM, Witztum JL, Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 1997;100:2995–3004.
   PubMed Web of Science ®Google Scholar
• Akude E, Zherebitskaya E, Roy Chowdhury SK, Girling K, Fernyhough P. 4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy. Neurotox Res 2010;17:28–38.
   PubMed Web of Science ®Google Scholar
• Zherebitskaya E, Akude E, Smith DR, Fernyhough P. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 2009;58:1356–1364; 2009.
   PubMed Web of Science ®Google Scholar
• Beretta G, Artali R, Regazzoni L, Panigati M, Facino RM. Glycyl-histidyl-lysine (GHK) is a quencher of alpha,beta- 4-hydroxy-trans-2-nonenal: a comparison with carnosine. insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques. Chem Res Toxicol 2007;20:1309–1314.
   PubMed Web of Science ®Google Scholar
• Dwivedi S, Sharma A, Patrick B, Sharma R, Awasthi YC. Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep 2007;12:4–10.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Niki E. 4-hydroxynonenal (4-HNE) has been widely accepted as an inducer of oxidative stress. Is this the whole truth about it or can 4-HNE also exert protective effects? IUBMB Life 2006;58:372–373.
   PubMed Web of Science ®Google Scholar
• Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 1997;94:4312–4317.
   PubMed Web of Science ®Google Scholar
• Demozay D, Mas JC, Rocchi S, Van Obberghen E. FALDH reverses the deleterious action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal on insulin signaling in 3T3-L1 adipocytes. Diabetes 2008;57:1216–1226.
   PubMed Web of Science ®Google Scholar
• Grimsrud PA, Picklo MJ, Sr, Griffin TJ, Bernlohr DA. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 2007;6:624–637.
   PubMed Web of Science ®Google Scholar
• Reagan LP, Magarinos AM, Yee DK, Swzeda LI, Van Bueren A, McCall AL, McEwen BS. Oxidative stress and HNE c onjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res 2000;862:292–300.
   PubMed Web of Science ®Google Scholar
• Sasson S, Eckel J. Disparate effects of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid in vascular endothelial and smooth muscle cells and in cardiomyocytes. Arch Physiol Biochem 2006;112:119–129.
   PubMedGoogle Scholar
• Totary-Jain H, Naveh-Many T, Riahi Y, Kaiser N, Eckel J, Sasson S. Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Circ Res 2005;97:1001–1008.
   PubMed Web of Science ®Google Scholar
• Araya Y, Kasuga J, Toyota K, Hirakawa Y, Oyama T, Makishima M, Morikawa K, Hashimoto Y, Miyachi H. Structure-based design and synthesis of fluorescent PPARalpha/delta co-agonist and its application as a probe for fluorescent polarization assay of PPARdelta ligands. Chem Pharm Bull (Tokyo) 2008;56:1357–1359.
   PubMed Web of Science ®Google Scholar
• Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to drug discovery. J Med Chem 2000;43:527–550.
   PubMed Web of Science ®Google Scholar
• Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J. Oxidative stress in hemodialysis. Contrib Nephrol 2008;161:132–137.
   PubMed Web of Science ®Google Scholar
• Nistala R, Whaley-Connell A, Sowers JR. Redox control of renal function and hypertension. Antioxid Redox Signal 2008;10:2047–2089.
   PubMed Web of Science ®Google Scholar
• Martin CJ, Goeddeke-Merickel CM. Oxidative stress in chronic kidney disease. Nephrol Nurs J 2005;32:683–685.
   PubMedGoogle Scholar
• Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272–1280.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2005;15(Suppl 1):77–80.
   Web of Science ®Google Scholar
• Huang KC, Yang CC, Lee KT, Chien CT. Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water. Kidney Int 2003;64:704–714.
   PubMed Web of Science ®Google Scholar
• Siems W. I. Wiswedel, F. Carluccio, T. Grune, L. Hennig, H. Hampl: Oxidative stress in cardio-renal anemia syndrome. Cardionephrology VIII European Meeting Assisi (M. Timio, V. Wizemann, S. Venanzi.), Editoriale Bios, Cosenza, 2004, 77–79.
   Google Scholar
• Levin A. The relationship of haemoglobin level and survival: direct or indirect effects? Nephrol Dial Transplant 2002;17(Suppl 5):8–13.
   PubMedGoogle Scholar
• Kokot F, Wiecek A. Evidence that the anemia of renal failure participates in overall uremic toxicity. Kidney Int Suppl 1997;62:83–86.
   Google Scholar
• Stenvinkel P, Barany P. Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress. Nephrol Dial Transplant 2002;17(Suppl 5):32–37.
   PubMedGoogle Scholar
• Silverberg DS, Iaina A, Wexler D, Blum M. The pathological consequences of anaemia. Clin Lab Haematol 2001;23:1–6.
   PubMedGoogle Scholar
• Carluccio F, Siems W, Stefanelli G, Sommerburg O, Grune T, Riedel E, Hampl H. Homocysteine in chronic renal failure in relation to renal anemia and to oxidative stress parameters 4-hydroxynonenal and malondialdehyde. Clin Nephrol 2002;58(Suppl 1):26–30.
   Web of Science ®Google Scholar
• Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Hampl H, Riehle M, Sommerburg O. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 2002;58(Suppl 1):12–19.
   Web of Science ®Google Scholar
• Grune T, Sommerburg O, Siems WG. Oxidative stress in anemia. Clin Nephrol 2000;53:18–22.
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Wexler D, Blum M, Tchebiner J, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Zubkov A, Steinbruch S, Iaina A. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. Clin Nephrol 2002;58(Suppl 1):37–45.
   Web of Science ®Google Scholar
• Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Kraemer K, Hampl H, Sommerburg O. Oxidative stress in cardio renal anemia syndrome: correlations and therapeutic possibilities. Clin Nephrol 2003;60(Suppl 1): 22–30.
   PubMed Web of Science ®Google Scholar
• Galli F, Ghibelli L, Buoncristiani U, Bordoni V, D’Intini V, Benedetti S, Canestrari F, Ronco C, Floridi A. Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E. Nephrol Dial Transplant 2003;18:1592–1600.
   PubMed Web of Science ®Google Scholar
• Noordzij MJ, Lefrandt JD, Smit AJ. Advanced glycation end products in renal failure: an overview. J Ren Care 2008;34:207–212.
   PubMedGoogle Scholar
• Cottone S, Lorito MC, Riccobene R, Nardi E, Mule G, Buscemi S, Geraci C, Guarneri M, Arsena R, Cerasola G. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 2008;21:175–179.
   PubMed Web of Science ®Google Scholar
• Siems W, Carluccio F, Radenkovic S, Grune T, Hampl H. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment. Kidney Blood Press Res 2005;28:295–301.
   PubMed Web of Science ®Google Scholar
• Wiswedel I, Hirsch D, Carluccio F, Hampl H, Siems W. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure. Biofactors 2005;24:201–208.
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol 2003;60(Suppl 1):93–102.
   PubMed Web of Science ®Google Scholar
• Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation 2003;107:992–995.
   PubMed Web of Science ®Google Scholar
• Beier A, Siems W, Brenke R, Grune T. [Increased formation of free radicals in chronic lymphedema]. Z Lymphol 1994;18:8–11.
   PubMedGoogle Scholar
• Brenke R, Siems W. The role of free radicals in lymphedema-an overview. Lymphology 2004;37(suppl):157–167.
   Google Scholar
• Siems W, Brenke R, Wiswedel I, Sommerburg O, Eckl PM, Bresgen N. In chronic lymphoedema increased oxysterol levels were measured. LymphForsch 2009;13:29–33.
   Google Scholar
• Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997;22:287–305.
   PubMed Web of Science ®Google Scholar
• Schwartz Y, Dushkin MI, Komarova NI, Vorontsova EV, Kuznetsova IS. Cholesterol-induced stimulation of postinflammatory liver fibrosis. Bull Exp Biol Med 2008;145:692–695.
   PubMed Web of Science ®Google Scholar
• Poli G, Schaur RJ, Siems WG, Leonarduzzi G. 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 2008;28:569–631.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Nagy E, Lengyel G, Feher J. The preventive role of coenzyme Q10 and other antioxidants in injuries caused by oxidative stress. Arch Med Sci 2007;3:1–5.
   Web of Science ®Google Scholar
• Feher J, Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). J Int Med Res 2003;31:537–551.
   PubMed Web of Science ®Google Scholar
• Feher J, Nemeth E, Lengyel G. Non-alcoholic steatohepatitis (NASH)- is it a part of the metabolic syndrome? Arch Med Sci 2005;1:37–47.
   Google Scholar
• Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008;14:193–199.
   PubMed Web of Science ®Google Scholar
• Hagymasi K, Lengyel G, Nagy E, Pallai ZS, Kocsis I, Feher J, Tulassay Z, Blazovics A. Impaired antioxidant status in non-organ specific autoantibody positive patients with non-alcoholic liver desease. Hung Med 2008;2:563–570.
   Google Scholar
• Eiszrich A, Feher J. Fatty liver in childhood. Hung Med 1999;2:519–531.
   Google Scholar
• Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413–1419.
   PubMed Web of Science ®Google Scholar
• Szantho A, Grigorescu M, Dumitra I, Serban A. Steatosis in hepatitis C virusinfection. Response to anti-viral therapy. J Gastrointestin Liver Dis 2006;15:117–124.
   PubMedGoogle Scholar
• Feher J, Lengyel G. Silymarin in the treatment of chronic liver diseases: past and future. Clin Exp Med 2009;3:403–413.
   Google Scholar
• Conde de la Rosa L, Moshage H, Nieto N. [Hepatocyte oxidant stress and alcoholic liver disease]. Rev Esp Enferm Dig 2008;100:156–163.
   PubMed Web of Science ®Google Scholar
• Cerutti PA. Prooxidant states and tumor promotion. Science 1985;227:375–381.
   PubMed Web of Science ®Google Scholar
• Szent-Gyorgyi A, Isenberg I, Baird SL. On the electron donating properties of carcinogens. Proc Natl Acad Sci USA 1960;46:1444–1449.
   PubMed Web of Science ®Google Scholar
• Sullivan PD. Free radicals of benzo(a)pyrene and derivatives. Environ Health Perspect 1985;64:283–295.
   PubMed Web of Science ®Google Scholar
• Emerit I, Cerutti PA. Tumour promoter phorbol-12-myristate-13-acetate induces chromosomal damage via indirect action. Nature 1981;293:144–146.
   PubMed Web of Science ®Google Scholar
• Zarkovic N. Antioxidatien in der prävention und chemotherapie von tumoren. Pharmazeutishe Zeitung 2000;145:391–395.
   Google Scholar
• Zarkovic J. Mechanismus der tumorentstehung. Pharmazeutishe Zeitung 2000;145:239–245.
   Google Scholar
• Singhal SS, Awasthi YC, Awasthi S. Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res 2006;66:2354–2360.
   PubMed Web of Science ®Google Scholar
• Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, Awasthi S. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 2007;67:4382–4389.
   PubMed Web of Science ®Google Scholar
• McKusick VA, Ruddle FH. The status of the gene map of the human chromosomes. Science 1977;196:390–405.
   PubMed Web of Science ®Google Scholar
• Edwards RH. Inheritance of the Dubin-Johnson-Sprinz syndrome. Gastroenterology 1975;68:734–749.
   PubMed Web of Science ®Google Scholar
• Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991;10:2247–2258.
   PubMed Web of Science ®Google Scholar
• Johnson D, Travis J. The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem 1979;254:4022–4026.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–867.
   PubMed Web of Science ®Google Scholar
• Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003;24:353–362.
   PubMed Web of Science ®Google Scholar
• Konturek PC, Konturek SJ, Brzozowski T. Gastric cancer and Helicobacter pylori infection. J Physiol Pharmacol 2006;57(Suppl 3):51–65.
   Google Scholar
• von Sonntag C. New aspects in the free-radical chemistry of pyrimidine nucleobases. Free Radic Res Commun 1987;2:217–224.
   PubMedGoogle Scholar
• Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res 1992;275:331–342.
   PubMed Web of Science ®Google Scholar
• Demple B, Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 1994;63:915–948.
   PubMed Web of Science ®Google Scholar
• Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361–370.
   PubMed Web of Science ®Google Scholar
• Cooke JP. NO and angiogenesis. Atheroscler 2003;4(Suppl 4): 53–60.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004;44:239–267.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1–40.
   PubMed Web of Science ®Google Scholar
• Miyake H, Hara I, Kamidono S, Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol 2004;171:1533–1536.
   PubMed Web of Science ®Google Scholar
• Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005;42:127–141.
   PubMed Web of Science ®Google Scholar
• Diakowska D, Lewandowski A, Kopec W, Diakowski W, Chrzanowska T. Oxidative DNA damage and total antioxidant status in serum of patients with esophageal squamous cell carcinoma. Hepatogastroenterology 2007;54:1701–1704.
   PubMedGoogle Scholar
• Tanaka H, Fujita N, Sugimoto R, Urawa N, Horiike S, Kobayashi Y, Iwasa M, Ma N, Kawanishi S, Watanabe S, Kaito M, Takei Y. Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C. Br J Cancer 2008;98:580–586.
   PubMed Web of Science ®Google Scholar
• Kawanishi S, Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 2006;8:1047–1058.
   PubMed Web of Science ®Google Scholar
• Shen HM, Ong CN. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutat Res 1996;366:23–44.
   PubMed Web of Science ®Google Scholar
• Nishigori C, Hattori Y, Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 2004;6:561–570.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Iwasa Y, Kondo S, Hiai H, Toyokuni S. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999;18:3793–3797.
   PubMed Web of Science ®Google Scholar
• West JD, Marnett LJ. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol 2006;19:173–194.
   PubMed Web of Science ®Google Scholar
• Ohshima H. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol Lett 2003;140–141:99–104.
   PubMed Web of Science ®Google Scholar
• Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276–285.
   PubMed Web of Science ®Google Scholar
• Bartsch H, Nair J. Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res 2005;591:34–44.
   PubMed Web of Science ®Google Scholar
• Irigaray P, Newby JA, Clapp R, Hardell L, Howard V, Montagnier L, Epstein S, Belpomme D. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother 2007;61:640–658.
   PubMed Web of Science ®Google Scholar
• Nair J, Gal A, Tamir S, Tannenbaum SR, Wogan GN, Bartsch H. Etheno adducts in spleen DNA of SJL mice stimulated to overproduce nitric oxide. Carcinogenesis 1998;19:2081–2084.
   PubMed Web of Science ®Google Scholar
• Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, De Marzo AM. Cyclooxygenases in cancer: progress and perspective. Cancer Lett 2004;215:1–20.
   PubMed Web of Science ®Google Scholar
• Schmid K, Nair J, Winde G, Velic I, Bartsch H. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int J Cancer 2000;87:1–4.
   PubMed Web of Science ®Google Scholar
• Lock K, Pomerleau J, Causer L, Altmann DR, McKee M. The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ 2005;83:100–108.
   PubMed Web of Science ®Google Scholar
• Pierre F, Tache S, Gueraud F, Rerole AL, Jourdan ML, Petit C. Apc mutation induces resistance of colonic cells to lipoperoxide-triggered apoptosis induced by faecal water from haem-fed rats. Carcinogenesis 2007;28:321–327.
   PubMed Web of Science ®Google Scholar
• Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, Redl H, Waeg G, Borovic S, Loncaric I, Juric G, Hlavka V. 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci 1999;65:1901–1904.
   PubMed Web of Science ®Google Scholar
• Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 1999;274:2234–2242.
   PubMed Web of Science ®Google Scholar
• Masotti L, Casali E, Galeotti T. Lipid peroxidation in tumour cells. Free Radic Biol Med 1988;4:377–386.
   PubMed Web of Science ®Google Scholar
• Burton GW, Ingold KU, Cheeseman KH, Slater TF. Application of deuterated alpha-tocopherols to the biokinetics and bioavailability of vitamin E. Free Radic Res Commun 1990;11:99–107.
   PubMed Web of Science ®Google Scholar
• Huang ZZ, Li H, Cai J, Kuhlenkamp J, Kaplowitz N, Lu SC. Changes in glutathione homeostasis during liver regeneration in the rat. Hepatology 1998;27:147–153.
   PubMed Web of Science ®Google Scholar
• Marquez-Quinones A, Cipak A, Zarkovic K, Fattel-Fazenda S, Villa-Trevino S, Waeg G, Zarkovic N, Gueraud F. HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res 2010;44:119–127.
   PubMed Web of Science ®Google Scholar
• Zivkovic M, Zarkovic K, Ljubomir S, Waeg G, Poljak-Blazi M, Borovic S, Schaur J, Zarkovic N. A new method for detection of HNE-histidine conjugates in rat inflammatory cells. Croatica Chemica Acta 2005;78:91–98.
   Web of Science ®Google Scholar
• Yelisyeyeva O, Cherkas A, Zarkovic K, Semen K, Kaminskyy D, Waeg G, Zarkovic N. The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients. Free Radic Res 2008;42:205–211.
   PubMed Web of Science ®Google Scholar
• Cherkas A, Yelisyeyeva O, Semen K, Zarkovic K, Kaminskyy D, Gasparovic AC, Jaganjac M, Lutsyk A, Waeg G, Zarkovic N. Persistent accumulation of 4-hydroxynonenal-protein adducts in gastric mucosa after Helicobacter pylori eradication. Coll Antropol 2009;33:815–821.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Robbesyn F, Poli G. Signaling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 2004;37:1694–1702.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 1997;11:851–857.
   PubMed Web of Science ®Google Scholar
• Kreuzer T, Grube R, Wutte A, Zarkovic N, Schaur RJ. 4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells. Free Radic Biol Med 1998;25:42–49.
   PubMed Web of Science ®Google Scholar
• Biasi F, Vizio B, Mascia C, Gaia E, Zarkovic N, Chiarpotto E, Leonarduzzi G, Poli G. C-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. Free Radic Biol Med 2006;41:443–454.
   PubMed Web of Science ®Google Scholar
• Biasi F, Tessitore L, Zanetti D, Cutrin JC, Zingaro B, Chiarpotto E, Zarkovic N, Serviddio G, Poli G. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. Gut 2002;50:361–367.
   PubMed Web of Science ®Google Scholar
• Zarkovic K, Uchida K, Kolenc D, Hlupic L, Zarkovic N. Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic Res 2006;40:543–552.
   PubMed Web of Science ®Google Scholar
• Custovic Z, Zarkovic K, Cindric M, Cipak A, Jurkovic I, Sonicki Z, Uchida K, Zarkovic N. Lipid peroxidation product acrolein as a predictive biomarker of prostate carcinoma relapse after radical surgery. Free Radic Res 2010;44:497–504.
   PubMed Web of Science ®Google Scholar
• Abel T, Feher J. [Non-alcoholic fatty liver disease and cardiovascular risk]. Orv Hetil 2008;149:1299–1305.
   PubMedGoogle Scholar
• Karabulut AB, Kafkasli A, Burak F, Gozukara EM. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 2005;23:279–283.
   PubMed Web of Science ®Google Scholar
• Zeteroglu S, Ustun Y, Ustun YE. Placental and cord malondialdehyde and maternal and perinatal outcomes. Int J Gynaecol Obstet 2004;85:47–49.
   PubMed Web of Science ®Google Scholar